The evolutionary history of lethal metastatic prostate cancer
ICGC Prostate UK Group(Wellcome Sanger Institute), Gunes Gundem(Cancer Research UK), Peter Van Loo(Cancer Research UK), Bárbara Kremeyer(Wellcome Sanger Institute), Ludmil B. Alexandrov(Wellcome Sanger Institute), José M. C. Tubío(Wellcome Sanger Institute), Elli Papaemmanuil(University of East Anglia), Daniel S. Brewer(University of East Anglia), Heini Kallio(Tampere University), Gunilla Högnäs(Tampere University), Matti Annala(Tampere University), Kati Kivinummi(Tampere University), Victoria Goody(Wellcome Sanger Institute), Calli Latimer(Wellcome Sanger Institute), Sarah O’Meara(Wellcome Sanger Institute), Kevin J. Dawson(Johns Hopkins University), William B. Isaacs(National Institutes of Health), Michael R. Emmert‐Buck(National Institutes of Health), Matti Nykter(University of Liverpool), Christopher S. Foster(Institute of Cancer Research), Zsofia Kote‐Jarai(Institute of Cancer Research), Douglas F. Easton(University of Cambridge), Hayley C. Whitaker(University of Cambridge), David E. Neal(University of East Anglia), Colin S. Cooper(University of East Anglia), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Tapio Visakorpi(Tampere University), Peter J. Campbell(Wellcome Sanger Institute), Ultan McDermott(Wellcome Sanger Institute), David C. Wedge(Tampere University), G. Steven Bova(Tampere University)
Cited by 1,434Open Access